Medplus Health Services (NSE:MEDPLUS) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
85 GF Score
Price ₹720.55
GF Value ₹959.11
Valuation Modestly Undervalued
View Full Analysis

What is Medplus Health Services Other Current Receivables?

Medplus Health Services NSE:MEDPLUS +0.75% 85 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 85/100 and a GF Value™ of ₹959.11 (Modestly Undervalued).

Medplus Health Services's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Medplus Health Services's annual Other Current Receivables increased from Mar. 2024 (₹105.60 Mil) to Mar. 2025 (₹115.76 Mil) and increased from Mar. 2025 (₹115.76 Mil) to Mar. 2026 (₹221.30 Mil).

Medplus Health Services Other Current Receivables Related Terms

Medplus Health Services Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Medplus Health Services's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medplus Health Services Other Current Receivables Chart

Medplus Health Services Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial 399.04 67.72 105.60 115.76 221.30

Medplus Health Services Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 221.30 0.00
NSE:MEDPLUS
85GF Score
Medplus Health Services Ltd NSE:MEDPLUS
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medplus Health Services Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Medplus Health Services (NSE:MEDPLUS) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medplus Health Services and its competitors.
Is Medplus Health Services' Other Current Receivables too high?
Medplus Health Services' current Other Current Receivables is ₹0 Mil. Overall, Medplus Health Services has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' Other Current Receivables compare to competitors?
Medplus Health Services' Other Current Receivables of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medplus Health Services and its competitors. Medplus Health Services's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹959.11, compared to a current price of ₹720.55 — trading 24.9% below its estimated fair value. The current Other Current Receivables is ₹0 Mil. Medplus Health Services' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹720.55 is trading 24.9% below its estimated GF Value™ of ₹959.11. GuruFocus considers Medplus Health Services to be Modestly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹959.11 vs. price of ₹720.55 (24.9% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
85GF Score

Get the complete analysis for NSE:MEDPLUS

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹720.55
Price
₹959.11
GF Value